T1	Outcomes 0 17	Long-term outcome
T2	Outcomes 246 291	predict the efficacy of antimigraine therapy.
T3	Outcomes 516 545	maintained treatment benefit,
T4	Outcomes 554 620	benefit was lost in patients with an early onset migraine response